"We obviously still need to manage the short-term challenges but, as an industry, we have to show leadership on the future and working with the government to ensure Australian patients are in a position to access these new technologies," says Novartis' Lauren Carey. …
Lauren Carey: Review a 'great opportunity' to shape future
September 18, 2019 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
Lundbeck announces its new leadership for Australia and NZ
November 8, 2024 - - Latest News -
ACCC will not oppose Sigma-Chemist Warehouse merger, subject to undertaking
November 8, 2024 - - Latest News -
AusBiotech and MTPConnect launch joint discussion paper on life science growth issues
November 8, 2024 - - Latest News -
Global Biosimilars Week to highlight the health and financial benefits of biosimilar medicines
November 8, 2024 - - Latest News -
Officials 'gauged' evaluator capacity after the minister endorsed their plan
November 7, 2024 - - Latest News -
AusBiotech and Life Sciences Western Australia sign first-ever MOU
November 7, 2024 - - Australian Biotech -
The solution simply gives some certainty to submissions that had none
November 7, 2024 - - Latest News